Microbiome in development of esophageal diseases
Aim of review. To present up-to-date data on microbiome role in development of various esophageal diseases and options of probiotics application in esophageal diseases treatment. Summary. Gastro-intestinal microbiome is an invisible organ of our body integrating about 1014 microorganisms. Main bacte...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Gastro LLC
2016-08-01
|
| Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| Subjects: | |
| Online Access: | https://www.gastro-j.ru/jour/article/view/55 |
| _version_ | 1797245242089406464 |
|---|---|
| author | Yu. V. Yevsyutina V. T. Ivashkin |
| author_facet | Yu. V. Yevsyutina V. T. Ivashkin |
| author_sort | Yu. V. Yevsyutina |
| collection | DOAJ |
| description | Aim of review. To present up-to-date data on microbiome role in development of various esophageal diseases and options of probiotics application in esophageal diseases treatment. Summary. Gastro-intestinal microbiome is an invisible organ of our body integrating about 1014 microorganisms. Main bacteria types for the esophagus are Firmicutes, Bacteroidetes, Actinobacteria, Proteobacteria, Fusobacteria and TM7. The microbiome of the normal esophageal mucosa is represented by gram-positive bacteria like Firmicutes; microbiome in patients with Barret's esophagus and esophagitis is constituted mainly by gram-negative anaerobe bacteria: Bacteroidetes, Proteobacteria, Fusobacteria and Spirochaete; patients with eosinophilic esophagitis have Proteobacteria. Expression of tumor and inflammatory mediators (toll-like receptors, interleukins, nuclear factor κB, cyclooxygenase-2) can be determined by microbiome pattern. Conclusion. Results of original studies demonstrate microbiome changes of the esophagus at gastroesophageal reflux disease, Barret's esophagus, adenocarcinoma of the esophagus and eosinophilic esophagitis. Toll-like receptors, cytokines, nuclear factor κB, cyclooxygenase-2 can be potential mediators of inflammation and carcinogenesis which expression can be modified by microbiome spectrum. Probiotics can become the priority trend in treatment of diseases of the esophagus. |
| first_indexed | 2024-03-08T09:21:44Z |
| format | Article |
| id | doaj.art-15730aafc2ac4458b51cf449ee257602 |
| institution | Directory Open Access Journal |
| issn | 1382-4376 2658-6673 |
| language | Russian |
| last_indexed | 2024-04-24T19:23:47Z |
| publishDate | 2016-08-01 |
| publisher | Gastro LLC |
| record_format | Article |
| series | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| spelling | doaj.art-15730aafc2ac4458b51cf449ee2576022024-03-25T16:53:07ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732016-08-01263111610.22416/1382-4376-2016-26-3-11-1655Microbiome in development of esophageal diseasesYu. V. Yevsyutina0V. T. Ivashkin1State educational government-financed institution of higher professional education «Sechenov First Moscow state medical university»State educational government-financed institution of higher professional education «Sechenov First Moscow state medical university»Aim of review. To present up-to-date data on microbiome role in development of various esophageal diseases and options of probiotics application in esophageal diseases treatment. Summary. Gastro-intestinal microbiome is an invisible organ of our body integrating about 1014 microorganisms. Main bacteria types for the esophagus are Firmicutes, Bacteroidetes, Actinobacteria, Proteobacteria, Fusobacteria and TM7. The microbiome of the normal esophageal mucosa is represented by gram-positive bacteria like Firmicutes; microbiome in patients with Barret's esophagus and esophagitis is constituted mainly by gram-negative anaerobe bacteria: Bacteroidetes, Proteobacteria, Fusobacteria and Spirochaete; patients with eosinophilic esophagitis have Proteobacteria. Expression of tumor and inflammatory mediators (toll-like receptors, interleukins, nuclear factor κB, cyclooxygenase-2) can be determined by microbiome pattern. Conclusion. Results of original studies demonstrate microbiome changes of the esophagus at gastroesophageal reflux disease, Barret's esophagus, adenocarcinoma of the esophagus and eosinophilic esophagitis. Toll-like receptors, cytokines, nuclear factor κB, cyclooxygenase-2 can be potential mediators of inflammation and carcinogenesis which expression can be modified by microbiome spectrum. Probiotics can become the priority trend in treatment of diseases of the esophagus.https://www.gastro-j.ru/jour/article/view/55микробиомэзофагитпищевод барретааденокарцинома пищеводаэозинофильный эзофагитпробиотики |
| spellingShingle | Yu. V. Yevsyutina V. T. Ivashkin Microbiome in development of esophageal diseases Российский журнал гастроэнтерологии, гепатологии, колопроктологии микробиом эзофагит пищевод баррета аденокарцинома пищевода эозинофильный эзофагит пробиотики |
| title | Microbiome in development of esophageal diseases |
| title_full | Microbiome in development of esophageal diseases |
| title_fullStr | Microbiome in development of esophageal diseases |
| title_full_unstemmed | Microbiome in development of esophageal diseases |
| title_short | Microbiome in development of esophageal diseases |
| title_sort | microbiome in development of esophageal diseases |
| topic | микробиом эзофагит пищевод баррета аденокарцинома пищевода эозинофильный эзофагит пробиотики |
| url | https://www.gastro-j.ru/jour/article/view/55 |
| work_keys_str_mv | AT yuvyevsyutina microbiomeindevelopmentofesophagealdiseases AT vtivashkin microbiomeindevelopmentofesophagealdiseases |